Article Text
Abstract
Allograft shortage is a formidable obstacle in organ transplantation. Xenotransplantation, the interspecies transplantation of cells, tissues, and organs, or ex vivo interspecies exchange between cells, tissues, and organs is a frequently suggested alternative to this allograft shortage. As xenotransplantation steadily improves into a viable allotransplantation alternative, several bioethical considerations coalesce. Such considerations include the Helsinki declaration’s guarantee of patients’ rights to privacy; political red tape that may select for undermined socioeconomic groups as the first recipients of xenografts; industry incentives in xenotransplantation investments; conflicts of interest when a clinician supervises a patient as a research subject; the psychosocial impact of transplantation on the xenograft recipient, and the rights of animals. This review illuminates these issues through a conglomeration of expert opinion and relevant experimental studies.
- HPC, hepatitis C
- IACUC, Institutional Animal Care and Use Committees
- IRB, institutional review board
- NOTA, National Organ Transplant Act
- RAC, Recombinant DNA Advisory Council
- xenotransplantation
- animal rights
- bioethics
Statistics from Altmetric.com
Footnotes
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Reforming the politics of animal research
- Institution animal care and use committees need greater ethical diversity
- 737 A novel humanized murine model to identify neoantigen - specific T cells in pediatric acute megakaryoblastic leukemia
- Whistleblowing in academic medicine
- Starting clinical trials of xenotransplantation — reflections on the ethics of the early phase
- 167 B - cell - based vaccination elicit potent immunity against glioblastoma
- Rotary powered device for bone marrow aspiration and biopsy yields excellent specimens quickly and efficiently
- Cardiac transplantation
- Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor - positive ovarian or endometrial cancers
- In vivo therapeutic effects of affinity - improved - TCR engineered T-cells on HBV - related hepatocellular carcinoma